Summary of all studies containing PUBCHEM ID 7405
Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
---|---|---|---|---|---|
PR000001 | ST000001 | Fatb Induction Experiment (FatBIE) | Plant | Arabidopsis thaliana | oxoproline [Data] |
PR000002 | ST000002 | Intestinal Samples II pre/post transplantation | Human | Homo sapiens | oxoproline [Data] |
PR000005 | ST000006 | White Wine Study | Plant | Vitis vinifera | oxoproline [Data] |
PR000006 | ST000007 | Rice Infection Study | Plant | Oryza sativa Japonica Group | oxoproline [Data] |
PR000011 | ST000012 | Extraction Optimization Study | Plant | Chlamydomonas reinhardtii | oxoproline [Data] |
PR000012 | ST000013 | Mutation Study | Plant | Arabidopsis thaliana | oxoproline [Data] |
PR000013 | ST000014 | Skeletal Muscle Treatment (palmitate/palmitoyl carnitine) | Animal | Mus musculus | oxoproline [Data] |
PR000018 | ST000040 | Heatshock response of C. elegans using IROA (I) | Invertebrate | Caenorhabditis elegans | Pyroglutamic acid [Data] |
PR000024 | ST000025 | Metabolomics Analysis of Thermally Challenged Mayfly Larvae (GCMS analysis) | Insect | Centroptilum triangulifer;Atherix;Megaloptera | oxoproline [Data] |
PR000044 | ST000045 | Plasma metabolomics: Comparison of non-diabetic controls with T1D patients | Human | Homo sapiens | Pyroglutamicacid [Data] |
PR000044 | ST000045 | Plasma metabolomics: Comparison of non-diabetic controls with T1D patients | Human | Homo sapiens | Pyroglutamicacid+1.5019361 [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyroglutamicacid [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyroglutamicacid-1.2783064 [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyroglutamicacid-1.5171912 [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyroglutamicacid+5.8255005 [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyroglutamicacid+6.828353 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyroglutamicacid [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyroglutamicacid+1.2445769 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyroglutamicacid-1.3865262 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyroglutamicacid+1.5233006 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyroglutamicacid-1.5248408 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyroglutamicacid+6.857936 [Data] |
PR000046 | ST000048 | Metabolomic & lipidomic profiles in response to exogenous insulin & GLP-1 infusions during prolonged fasting (GCMS) | Animal | Mirounga angustirostris | oxoproline [Data] |
PR000051 | ST000054 | Metabolic Microenvironments in Normal Breast and Breast Cancer (MS analysis) | Human | Homo sapiens | oxoproline [Data] |
PR000054 | ST000057 | Combined Metabolomics and Lipidomics of Type 1 Diabetes (GCMS) | Animal | Mus musculus | oxoproline [Data] |
PR000055 | ST000058 | Metabolite changes associated with methionine stress sensitivity of cancer (GC TOF MS analysis) | Human cells | Homo sapiens | oxoproline [Data] |
PR000058 | ST000061 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: GC-TOF MS analyis of subcutaneous and visceral adipose tissue samples | Human | Homo sapiens | oxoproline [Data] |
PR000058 | ST000065 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: GC-TOF MS analyis of serum samples | Human | Homo sapiens | oxoproline [Data] |
PR000059 | ST000062 | Biomarkers for Depression in Human Plasma in a Population Sample | Human | Homo sapiens | oxoproline [Data] |
PR000059 | ST000063 | Biomarkers for Depression in Human Cerebrospinal Fluid in a Population Sample | Human | Homo sapiens | oxoproline [Data] |
PR000079 | ST000087 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: GC-TOF MS analysis | Human cells | Homo sapiens | oxoproline [Data] |
PR000084 | ST000092 | A statistical analysis of the effects of urease pre-treatment on the measurement of the urinary metabolome by gas chromatographymass spectrometry | Human | Homo sapiens | L-pyroglutamic acid [Data] |
PR000106 | ST000117 | Metabolomics analysis of multiple metabolic functions in the YjgF/YER057c/UK114 (Rid) protein family GC-MS (Part 1) | Bacterial cells | Salmonella enterica;Escherichia coli | oxoproline [Data] |
PR000106 | ST000118 | Metabolomics analysis of multiple metabolic functions in the YjgF/YER057c/UK114 (Rid) protein family GCMS (part 2) | Bacterial cells | Salmonella enterica;Escherichia coli | oxoproline [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Oxoproline-13C0[+13CD3 QDA]+ [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Oxoproline-13C0[+13CD3 QDA]+NH4 [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Oxoproline-13C0[+QDA adduct]+ [Data] |
PR000148 | ST000701 | Differences in metabolism in mouse embryonic fibroblasts (control vs SCF-beta-TrCP knockout) | Mouse | Mus musculus | 5-OXOPROLINE [Data] |
PR000148 | ST000701 | Differences in metabolism in mouse embryonic fibroblasts (control vs SCF-beta-TrCP knockout) | Mouse | Mus musculus | 5-OXOPROLINE + 1.1064999 [Data] |
PR000148 | ST000701 | Differences in metabolism in mouse embryonic fibroblasts (control vs SCF-beta-TrCP knockout) | Mouse | Mus musculus | 5-OXOPROLINE - 1.1521429 [Data] |
PR000148 | ST000701 | Differences in metabolism in mouse embryonic fibroblasts (control vs SCF-beta-TrCP knockout) | Mouse | Mus musculus | 5-OXOPROLINE + 1.193 [Data] |
PR000148 | ST000701 | Differences in metabolism in mouse embryonic fibroblasts (control vs SCF-beta-TrCP knockout) | Mouse | Mus musculus | 5-OXOPROLINE + 1.1945 [Data] |
PR000148 | ST000701 | Differences in metabolism in mouse embryonic fibroblasts (control vs SCF-beta-TrCP knockout) | Mouse | Mus musculus | 5-OXOPROLINE + 1.1962668 [Data] |
PR000165 | ST000693 | Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis (part II) | Mouse | Mus musculus | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000165 | ST000693 | Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis (part II) | Mouse | Mus musculus | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000166 | ST000694 | Differences in bile acids composition between ASCL5 knockout and floxed mice. | Mouse | Mus musculus | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000166 | ST000694 | Differences in bile acids composition between ASCL5 knockout and floxed mice. | Mouse | Mus musculus | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000166 | ST000694 | Differences in bile acids composition between ASCL5 knockout and floxed mice. | Mouse | Mus musculus | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ [Data] |
PR000188 | ST000235 | Sprague Dawley rats Nicotine alters brain oxidative metabolism | Animal | Rattus norvegicus | 5-OXO-L-PROLINE [Data] |
PR000193 | ST000240 | Global LC-MS of Ozone Stress in Maize: GLCMS | Plant | Zea mays | 5-OXO-L-PROLINE [Data] |
PR000196 | ST000243 | Metabolomic-based investigation on the effects of antifungal agents in Candida albicans | Yeast cells | Candida albicans | 5-OXO-L-PROLINE [Data] |
PR000197 | ST000244 | Metabolomic Diagnosis in Horse | Animal | Equus caballus | 5-OXO-L-PROLINE [Data] |
PR000200 | ST000248 | Metabolic heterogeneity in Glioblastoma | Human | Homo sapiens | 5-OXO-L-PROLINE [Data] |
PR000204 | ST000252 | Impact of recurrent hypoglycemia on brain metabolite profile | Animal | Rattus norvegicus | 5-OXO-L-PROLINE [Data] |
PR000208 | ST000256 | Signal Intensities Derived from Different NMR Probes and Parameters Contribute to Variations in Quantification of Metabolites | Human | Homo sapiens | Pyroglutamate [Data] |
PR000210 | ST000258 | Metabolic contribution of pSymA and pSymB megaplasmid/chromid for multipartite Sinorhizobium meliloti cultured in minimal M9 medium | Bacterial cells | Sinorhizobium meliloti | oxoproline [Data] |
PR000210 | ST000258 | Metabolic contribution of pSymA and pSymB megaplasmid/chromid for multipartite Sinorhizobium meliloti cultured in minimal M9 medium | Bacterial cells | Sinorhizobium meliloti | pyroglutamic acid [Data] |
PR000210 | ST000259 | Metabolic contribution of pSymA and pSymB megaplasmid/chromid for multipartite Sinorhizobium meliloti cultured in rich LBmc medium | Bacterial cells | Sinorhizobium meliloti | oxoproline [Data] |
PR000214 | ST000270 | Metabolomics in AML | Human | Homo sapiens | 5-OXO-L-PROLINE [Data] |
PR000226 | ST000284 | Colorectal Cancer Detection Using Targeted Serum Metabolic Profiling | Human | Homo sapiens | Pyroglutamic Acid [Data] |
PR000228 | ST000286 | Mouse skeletal myotube chronic low-frequency stimulation | Animal cells | Mus musculus | 5-OXO-L-PROLINE [Data] |
PR000230 | ST000288 | Metabolomic profiling of AML Cell Lines | Human | Homo sapiens | 5-OXO-L-PROLINE [Data] |
PR000231 | ST000289 | PPDK RNAi effects in endosperm metabolite pools | Plant | Zea mays | 5-OXO-L-PROLINE [Data] |
PR000232 | ST000290 | 2014 Biotron Experiment Metabolites | Plant | Zea mays | 5-OXO-L-PROLINE [Data] |
PR000232 | ST000564 | 2014 Biotron Experiment Metabolites (part II) | Plant | Zea mays | 5-OXO-L-PROLINE [Data] |
PR000233 | ST000291 | LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice | Human | Homo sapiens | 5-OXO-L-PROLINE [Data] |
PR000233 | ST000292 | LC-MS Based Approaches to Investigate Metabolomic Differences in the Plasma of Young Women after Drinking Cranberry Juice or Apple Juice | Human | Homo sapiens | 5-OXO-L-PROLINE [Data] |
PR000233 | ST000292 | LC-MS Based Approaches to Investigate Metabolomic Differences in the Plasma of Young Women after Drinking Cranberry Juice or Apple Juice | Human | Homo sapiens | 5-OXO-L-PROLINE_1 [Data] |
PR000233 | ST000292 | LC-MS Based Approaches to Investigate Metabolomic Differences in the Plasma of Young Women after Drinking Cranberry Juice or Apple Juice | Human | Homo sapiens | 5-OXO-L-PROLINE_2 [Data] |
PR000248 | ST000309 | Metabolome of three Vancomycin-intermediate Staphylococcus aureus (VISA) mutants compared with the parent strain MM66 | Bacterial cells | Staphylococcus aureus | Pyroglutamic acid [Data] |
PR000267 | ST000335 | Metabolomics of bovine uterine fluid at the onset of conceptus elongation | Animal | Bos taurus | Pyroglutamic acid_1 [Data] |
PR000267 | ST000335 | Metabolomics of bovine uterine fluid at the onset of conceptus elongation | Animal | Bos taurus | Pyroglutamic acid_2 [Data] |
PR000269 | ST000424 | Metabolomics Approach to Allograft Assessment in Liver Transplantation (part II) | Human | Homo sapiens | 5-OXO-L-PROLINE [Data] |
PR000281 | ST000352 | Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease | Animal | Mus musculus | 5-oxoproline [Data] |
PR000282 | ST000353 | The Development of Metabolomic Markers in African Bermudagrass (C. transvaalensis) for Sting Nematode (Belonolaimus longicaudatus) Response | Plant | Cynodon transvaalensis | Pyroglutamic Acid [Data] |
PR000293 | ST000369 | Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer (part II) | Human | Homo sapiens | oxoproline [Data] |
PR000298 | ST000379 | Temporal metabolomic responses of cultured HepG2 liver cells to high fructose and high glucose exposures | Cells | Homo sapiens | oxoproline [Data] |
PR000299 | ST000381 | Urinary Metabolites in IC/PBS Diagnosis (part I) | Human | Homo sapiens | oxoproline [Data] |
PR000302 | ST000386 | Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer (test/validation) | Human | Homo sapiens | oxoproline [Data] |
PR000304 | ST000389 | Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer (part II) | Human | Homo sapiens | oxoproline [Data] |
PR000305 | ST000390 | Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma (part I) | Human | Homo sapiens | oxoproline [Data] |
PR000307 | ST000393 | Long-Chain Fatty Acid Combustion Rate Is Associated with Unique Metabolite Profiles in Skeletal Muscle Mitochondria | Animal | Mus musculus | oxoproline [Data] |
PR000308 | ST000395 | The circadian oscillator in Synechococcus elongatus controls metabolite partitioning during diurnal growth (part II) | Cells | Synechococcus elongatus PCC 7942 | oxoproline [Data] |
PR000309 | ST000396 | Lung Cancer Plasma Discovery | Human | Homo sapiens | oxoproline [Data] |
PR000313 | ST000401 | Inhibition of diamine oxidase promotes uptake of putrescine from rat small intestine | Animal | Rattus norvegicus | oxoproline [Data] |
PR000316 | ST000404 | Role of HVCN1 in B cell malignancies | Cells | Homo sapiens | oxoproline [Data] |
PR000322 | ST000412 | Metabolic profiling during ex vivo machine perfusion of the human liver (part I) | Human | Homo sapiens | oxoproline [Data] |
PR000344 | ST000446 | Heterologous expression and detection of Apratoxins in E. coli | bacteria cells | Escherichia coli | Pyroglutamic Acid [Data] |
PR000348 | ST000450 | Metabolic features of chronic fatigue syndrome | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR000349 | ST000451 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data | Animal | Mus musculus | 5-Oxoproline [Data] |
PR000349 | ST000452 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data | Animal | Mus musculus | 5-Oxoproline [Data] |
PR000357 | ST000465 | Uniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response | Human renal cancer cells | Homo sapiens | Pyroglutamic acid [Data] |
PR000362 | ST000475 | Metabolomic testing of a putative MDH inhibitor (global) | Human leukemia cells | Homo sapiens | Pyroglutamic Acid [Data] |
PR000374 | ST000497 | M-CMV infected Nicotiana tabacum | LC-MS & GC-MS | Nicotiana tabacum | 5-oxoproline [Data] |
PR000375 | ST000555 | Cocaine administration and withdrawal (part II) | Long Evans Rat | Rattus norvegicus | 5-OXO-L-PROLINE [Data] |
PR000381 | ST000508 | Metabolic Profiling of Date Palm Fruits | Date palm fruit | Phoenix dactylifera | 5-oxoproline [Data] |
PR000381 | ST000867 | Metabolic Profiling of Date Palm Fruits (part II) | Date palm fruit | Phoenix dactylifera | 5-oxoproline [Data] |
PR000396 | ST000541 | Canine Diabetes - Preliminary Evaluation of Testing Methods | Animal | Canis lupus familiaris | 5-OXO-L-PROLINE [Data] |
PR000404 | ST000552 | Metabolite signatures in trauma patients with venous thromboembolism (VTE) | Human | Homo sapiens | Pyroglutamic Acid [Data] |
PR000406 | ST000554 | Metabolomics of aged iPSC | Animal | Mus musculus | 5-OXO-L-PROLINE [Data] |
PR000407 | ST000556 | IROA feasibility project; plasticizers as obesogens in zebrafish | Larval fish at one month | Danio rerio | 5-OXO-L-PROLINE [Data] |
PR000412 | ST000561 | Exploring the link between genotype, phenotype and metabolome for tomato seed quality attributes | Plant | Solanum lycopersicum | Pyroglutamate [Data] |
PR000414 | ST000692 | Metabolites produced by strains associated with inflammation | Bacteria | Treponema pectinovorum | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000414 | ST000692 | Metabolites produced by strains associated with inflammation | Bacteria | Treponema pectinovorum | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000417 | ST000569 | Effect of minimal and complex media on the metabolite profiles | Microorganisms | Saccharomyces cerevisiae | oxoproline [Data] |
PR000419 | ST000571 | Metabolomics of uterine fluid of the cow | Animal | Bos taurus | 5-OXO-L-PROLINE [Data] |
PR000420 | ST000572 | Metabolomics of Shark Bay stromatolites | bacterial microbial community | Mixed | 5-OXO-L-PROLINE [Data] |
PR000451 | ST000617 | Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR000461 | ST000658 | Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice (part IV) | Animal | Mus musculus | oxoproline [Data] |
PR000461 | ST000660 | Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice (part I) | Animal | Mus musculus | oxoproline [Data] |
PR000488 | ST000689 | Influence of Noxa knockdown on cell metabolism | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000488 | ST000689 | Influence of Noxa knockdown on cell metabolism | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000488 | ST000689 | Influence of Noxa knockdown on cell metabolism | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ [Data] |
PR000489 | ST000690 | Human oral keratinocytes growth and proliferation based on culture medium volume | Human | Homo sapiens | 5-OXOPROLINE [Data] |
PR000492 | ST000695 | Pilot metabolomics study of aromatase inhibitor associated arthralgias | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000492 | ST000695 | Pilot metabolomics study of aromatase inhibitor associated arthralgias | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000492 | ST000695 | Pilot metabolomics study of aromatase inhibitor associated arthralgias | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ [Data] |
PR000493 | ST000696 | Brain-Immune system-Gut Interaction in Chronic Mild Stress (CMS +/- Lacto) | Mouse | Mus musculus | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000493 | ST000696 | Brain-Immune system-Gut Interaction in Chronic Mild Stress (CMS +/- Lacto) | Mouse | Mus musculus | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000493 | ST000696 | Brain-Immune system-Gut Interaction in Chronic Mild Stress (CMS +/- Lacto) | Mouse | Mus musculus | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ [Data] |
PR000494 | ST000697 | Cytokines correlation with metabolomic profiling of psoriatic and normal skin | HUMAN | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000494 | ST000697 | Cytokines correlation with metabolomic profiling of psoriatic and normal skin | HUMAN | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000495 | ST000698 | Metabolomics analysis of Sirt5 knockdown (KD) melanoma | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000495 | ST000698 | Metabolomics analysis of Sirt5 knockdown (KD) melanoma | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000508 | ST000711 | Microbial ecology of nontuberculous mycobacteria (NTM) in cystic fibrosis (CF) sputum | Human | Homo sapiens | 5-OXOPROLINE (M+H)+ [Data] |
PR000510 | ST000713 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm | Human | Homo sapiens | 5-OXOPROLINE (M-H)- [Data] |
PR000510 | ST000713 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm | Human | Homo sapiens | 5-OXOPROLINE (M+H)+ [Data] |
PR000510 | ST000823 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | HUMAN | Homo sapiens | 5-OXOPROLINE (M-H)- [Data] |
PR000510 | ST000823 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | HUMAN | Homo sapiens | 5-OXOPROLINE (M+H)+ [Data] |
PR000510 | ST000823 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | HUMAN | Homo sapiens | 5-OXOPROLINE (M+Na)+ [Data] |
PR000511 | ST000714 | Effect of genetic lesions on glioblastoma (NP, NPA, NPAI, NS) | Mouse | Mus musculus | 5-OXOPROLINE (M-H)- [Data] |
PR000511 | ST000714 | Effect of genetic lesions on glioblastoma (NP, NPA, NPAI, NS) | Mouse | Mus musculus | 5-OXOPROLINE (M+H)+ [Data] |
PR000511 | ST000714 | Effect of genetic lesions on glioblastoma (NP, NPA, NPAI, NS) | Mouse | Mus musculus | 5-OXOPROLINE (M+NA)+ [Data] |
PR000519 | ST000722 | Metabolomics of Diapause in Aedes albopictus | Insect | Aedes albopictus | 5-OXOPROLINE (M+H)+ [Data] |
PR000521 | ST000724 | Red squirrels age related changes | Animal | Tamiasciurus hudsonicus | 5-OXOPROLINE (M-H)- [Data] |
PR000521 | ST000724 | Red squirrels age related changes | Animal | Tamiasciurus hudsonicus | 5-OXOPROLINE (M+H)+ [Data] |
PR000522 | ST000725 | Metabolome, body composition, and muscle performance in children | Human | Homo sapiens | 5-OXOPROLINE (M-H)- [Data] |
PR000522 | ST000725 | Metabolome, body composition, and muscle performance in children | Human | Homo sapiens | 5-OXOPROLINE (M+H)+ [Data] |
PR000523 | ST000726 | Polycystic Ovarian Syndrome(PCOS) metabolomics | Human | Homo sapiens | 5-OXOPROLINE (M-H)- [Data] |
PR000523 | ST000726 | Polycystic Ovarian Syndrome(PCOS) metabolomics | Human | Homo sapiens | 5-OXOPROLINE (M+H)+ [Data] |
PR000535 | ST000741 | Metabolite-phenotype link in X-linked Adrenoleukodystrophy (fibroblast cell culture) | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000535 | ST000741 | Metabolite-phenotype link in X-linked Adrenoleukodystrophy (fibroblast cell culture) | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000535 | ST000741 | Metabolite-phenotype link in X-linked Adrenoleukodystrophy (fibroblast cell culture) | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ [Data] |
PR000535 | ST000742 | Metabolite-phenotype link in X-linked Adrenoleukodystrophy (part II) | Human | Homo sapiens | 5-OXOPROLINE (M+H)+ [Data] |
PR000538 | ST000745 | Metabolomics of mice inoculated with human microbiota | Mouse | Mus musculus | 5-OXOPROLINE [Data] |
PR000538 | ST000746 | Metabolomics of mice inoculated with human stool (part II) | Mouse | Mus musculus | 5-OXOPROLINE [Data] |
PR000539 | ST000748 | Placental cells (BeWo) phthalate exposure metabolomics | Human | Homo sapiens | 5-OXOPROLINE (M-H)- [Data] |
PR000539 | ST000748 | Placental cells (BeWo) phthalate exposure metabolomics | Human | Homo sapiens | 5-OXOPROLINE (M+H)+ [Data] |
PR000540 | ST000749 | Rat amniotic fluid metabolomics | Rat | Rattus norvegicus | 5-OXOPROLINE (M-H)- [Data] |
PR000540 | ST000749 | Rat amniotic fluid metabolomics | Rat | Rattus norvegicus | 5-OXOPROLINE (M+H)+ [Data] |
PR000540 | ST000750 | Rat amniotic fluid metabolomics (part II) | Rat | Rattus norvegicus | 5-OXOPROLINE (M-H)- [Data] |
PR000540 | ST000750 | Rat amniotic fluid metabolomics (part II) | Rat | Rattus norvegicus | 5-OXOPROLINE (M+H)+ [Data] |
PR000541 | ST000751 | Mouse placentas-DEHP exposure | Mouse | Mus musculus | 5-OXOPROLINE (M-H)- [Data] |
PR000541 | ST000751 | Mouse placentas-DEHP exposure | Mouse | Mus musculus | 5-OXOPROLINE (M+H)+ [Data] |
PR000545 | ST000756 | Metabolomics of cilia and modulation of renal microcirculation | Rat | Rattus norvegicus | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000545 | ST000756 | Metabolomics of cilia and modulation of renal microcirculation | Rat | Rattus norvegicus | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000546 | ST000757 | Tubuloglomerular feedback and salt-sensitive hypertension | Rat | Rattus norvegicus | 5-OXOPROLINE (M+H)+ [Data] |
PR000547 | ST000758 | Effects of caloric restriction in HCR/LCR rats | Rat | Rattus norvegicus | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- [Data] |
PR000547 | ST000758 | Effects of caloric restriction in HCR/LCR rats | Rat | Rattus norvegicus | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000547 | ST000758 | Effects of caloric restriction in HCR/LCR rats | Rat | Rattus norvegicus | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ [Data] |
PR000551 | ST000763 | Untargeted metabolomics and lipidomics of scleroderma PAH discovery cohort | Human | Homo sapiens | 5-OXOPROLINE (M-H)- [Data] |
PR000551 | ST000763 | Untargeted metabolomics and lipidomics of scleroderma PAH discovery cohort | Human | Homo sapiens | 5-OXOPROLINE (M+H)+ [Data] |
PR000551 | ST000763 | Untargeted metabolomics and lipidomics of scleroderma PAH discovery cohort | Human | Homo sapiens | 5-OXOPROLINE (M+NA)+ [Data] |
PR000554 | ST000768 | Metabolites of human neurons and stem cells (siNeuron metabolomics) | HUMAN | Homo sapiens | 5-OXOPROLINE (M-H)- [Data] |
PR000554 | ST000768 | Metabolites of human neurons and stem cells (siNeuron metabolomics) | HUMAN | Homo sapiens | 5-OXOPROLINE (M+H)+ [Data] |
PR000561 | ST000775 | Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study | Human | Homo sapiens | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ [Data] |
PR000579 | ST000814 | Hormones & Cognition/Aging/Placebo | HUMAN | Homo sapiens | 5-OXOPROLINE [Data] |
PR000580 | ST000815 | db/db WT ozone and air exposed mice | db/db mouse and WT | Mus musculus | 5-oxoproline [Data] |
PR000599 | ST000841 | Metabolomics of muscle in insulin sensitive and resistant obese indivduals. | HUMAN | Homo sapiens | 5-OXOPROLINE (M-H)- [Data] |
PR000599 | ST000842 | Muscle and plasma before and after exercise | HUMAN | Homo sapiens | 5-OXOPROLINE (M-H)- [Data] |
PR000615 | ST000886 | Mechanism Behind Stay Green Trait in Bread Wheat (Triticum aestivum L.) | Plant | Triticum aestivum | 5-OXO-L-PROLINE_R1 [Data] |
PR000615 | ST000886 | Mechanism Behind Stay Green Trait in Bread Wheat (Triticum aestivum L.) | Plant | Triticum aestivum | 5-OXO-L-PROLINE_R2 [Data] |
PR000625 | ST000899 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Human serum | Homo sapiens | 5-oxoproline [Data] |
PR000626 | ST000900 | Evidence that the metabolite repair enzyme NAD(P)HX epimerase has a moonlighting function | Cells | Escherichia coli | oxoproline [Data] |
PR000627 | ST000903 | Pharmacometabolomic analysis of rat hippocampus and plasma in response to chronic stress and albiflorin treament | Animal | Rattus norvegicus | Pyroglutamic acid [Data] |
PR000631 | ST000910 | Insights into the pathogenesis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) through metabolomic profiling of cerebrospinal fluid (part I) | Human | Homo sapiens | oxoproline [Data] |
PR000635 | ST000919 | Investigating Eicosanoids Implications on the Blood Pressure Response to Thiazide Diuretics | Human | Homo sapiens | Pyroglutamic Acid [Data] |
PR000651 | ST000946 | Untargeted Metabolomics of T1 Participants | Human | Homo sapiens | PYROGLUTAMIC ACID (M-H) [Data] |
PR000651 | ST000946 | Untargeted Metabolomics of T1 Participants | Human | Homo sapiens | PYROGLUTAMIC ACID (M+H) [Data] |
PR000654 | ST000953 | Identification of putative cryoprotectant metabolites in Aphaenogaster picea | Insect | Aphaenogaster picea | 5-OXO-L-PROLINE [Data] |
PR000655 | ST000954 | Explore Metabolites and Pathways Associated Increased Airway Hyperresponsiveness in Asthma | Human | Homo sapiens | Pyroglutamic Acid [Data] |
PR000656 | ST000955 | Effects of ODC inhibition on T cell metabolism | Mammal | Mus musculus | Pyroglutamic Acid [Data] |
PR000658 | ST000957 | Global metabolomics of human milk fractions | Human | Homo sapiens | 5-OXO-L-PROLINE [Data] |
PR000664 | ST000968 | Impact of thiamine metabolites and spent medium from Chlorella sorokiniana on metabolism in the green algae Auxenochlorella prototheciodes (part I) | Cultured cells | Auxenochlorella protothecoides | oxoproline [Data] |
PR000664 | ST000969 | Impact of thiamine metabolites and spent medium from Chlorella sorokiniana on metabolism in the green algae Auxenochlorella prototheciodes (part II) | Cultured cells | Auxenochlorella protothecoides | oxoproline [Data] |
PR000665 | ST000972 | High Resolution GC-MS Metabolomics of Non-Human Primate Serum | Other | Papio hamadryas | Pyroglutamic acid [Data] |
PR000667 | ST001842 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part I) | Human | Homo sapiens | oxoproline [Data] |
PR000668 | ST000978 | Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: results from the Progredir Cohort. | Human | Homo sapiens | Pyroglutamic acid, TMS derivative [Data] |
PR000669 | ST000979 | Metabolomic profiles in healthy research cats receiving clindamycin with a synbiotic or a placebo: a randomized, controlled trial (Part I) | Animal | Felis catus | oxoproline [Data] |
PR000669 | ST000981 | Metabolomic profiles in healthy research cats receiving clindamycin with a synbiotic or a placebo: a randomized, controlled trial (Part II) | Other | Felis catus | oxoproline [Data] |
PR000692 | ST001034 | PAMP-triggered changes in the exometabolome of Arabidopsis suspension cells | Plant | Arabidopsis thaliana | oxoproline [Data] |
PR000694 | ST001037 | High Resolution GC-MS and FID Metabolomics of Human Serum | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR000697 | ST001041 | Development of a weaned pig model of enterotoxigenic E.coli-induced environmental enteropathy | Mammal | Sus scrofa | oxoproline [Data] |
PR000704 | ST001051 | High Salt Diet versus Low Salt Diet in rats | Mammal | Rattus norvegicus | oxoproline [Data] |
PR000721 | ST001076 | Multi-platform metabolomics data from Ndufs4-/- skeletal muscles (part - I) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR000721 | ST001077 | Multi-platform metabolomics data from Ndufs4-/- skeletal muscles (part-II) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR000727 | ST001088 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-I) | Invertebrate | Metacarcinus magister | oxoproline [Data] |
PR000727 | ST001166 | Physiological and metabolic response of pteropods to ocean acidification (part IV) | Invertebrate | Metacarcinus magister | oxoproline [Data] |
PR000737 | ST001101 | Identification of potential sepsis biomarkers in burn injury conditions. | Mammal | Mus musculus | oxoproline [Data] |
PR000741 | ST001110 | Investigating link between metabolism and circadian rhythm in Drosophila melanogaster | Insect | Drosophila melanogaster | oxoproline [Data] |
PR000747 | ST001163 | Variability in metabolomic profiles among unique genotypes of Acropora cervicornis (part-II) | Other | Acropora cervicornis | Pyroglutamic Acid [Data] |
PR000749 | ST001118 | Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature | Human | Homo sapiens | oxoproline [Data] |
PR000756 | ST001131 | Presentation of different serum metabolites in trauma patients versus healthy volunteers. | Human | Homo sapiens | oxoproline [Data] |
PR000758 | ST001133 | Downregulation of CENPF epigenetically remodels prostate cancer cells and alters cellular metabolism | Cultured cells | Homo sapiens | oxoproline [Data] |
PR000764 | ST001143 | Microbial depletion and ozone exposure - Lung tissue (part I) | Mammal | Mus musculus | 5-oxoproline [Data] |
PR000764 | ST001144 | Microbial depletion and ozone exposure - serum (part II) | Mammal | Mus musculus | 5-oxoproline [Data] |
PR000772 | ST001153 | Erythrocyte adenosine A2B receptor-mediated AMPK activation: Counteracting CKD by promoting oxygen delivery | Mammal | Mus musculus | 5-oxoproline [Data] |
PR000773 | ST001154 | A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium | Mammal | Mus musculus | oxoproline [Data] |
PR000776 | ST001157 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Mammal | Mus musculus | 5-oxoproline [Data] |
PR000776 | ST001158 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Mammal | Mus musculus | 5-oxoproline [Data] |
PR000801 | ST001189 | 1H NMR spectroscopy-based metabolic profiling of Ophiocordyceps sinensis and Cordyceps militaris of water-boiled and 50% ethanol-soaked extracts | Fungi | Ophiocordyceps sinensis;Cordyceps militaris | Pyroglutamate [Data] |
PR000803 | ST001191 | Metabolome of ginsenoside anti-tumor | Human | Homo sapiens | L-Pyroglutamic acid [Data] |
PR000814 | ST001211 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Homo sapiens | oxoproline [Data] |
PR000840 | ST001253 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Mammal | Mus musculus | 5-oxoproline [Data] |
PR000850 | ST001265 | Comparative metabolomics of MCF-7 breast cancer cells using different extraction solvents assessed by mass spectroscopy | Cultured cells | Homo sapiens | L-5-Oxoproline, , 2TMS derivative [Data] |
PR000850 | ST001265 | Comparative metabolomics of MCF-7 breast cancer cells using different extraction solvents assessed by mass spectroscopy | Cultured cells | Homo sapiens | Pyroglutamic acid, TMS derivative [Data] |
PR000867 | ST001282 | Role of Hi1a in mitochondrial metabolic rewiring in M1 Macrophages | Cultured cells | Mus musculus | oxoproline [Data] |
PR000867 | ST001283 | Nitric Oxide (NO) effect on mitochondrial metabolic rewiring in M1 Macrophages | Cultured cells | Mus musculus | oxoproline [Data] |
PR000873 | ST001291 | Metabolomic study of disease progression in scrapie prion infected (RML) mice | Mammal | Mus musculus | Pyroglutamate [Data] |
PR000895 | ST001318 | Atg32-mediated mitophagy promotes heat stress tolerance in Saccharomyces cerevisiae by sustaining spermidine and nitric oxide levels | Other | Saccharomyces cerevisiae | oxoproline [Data] |
PR000899 | ST001322 | Maternal adiposity alters the human milk metabolome: a link between non-glucose monosaccharides and infant adiposity | Human | Homo sapiens | oxoproline [Data] |
PR000901 | ST001324 | Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress | Invertebrate | Haliotis discus hannai | L-Pyroglutamic acid [Data] |
PR000902 | ST001325 | Obesity and Poor Diet as Susceptibility Factors for Secondhand Smoke in Childhood Asthma | Human | Homo sapiens | pyroglutamate [Data] |
PR000921 | ST001351 | NMR Metabolomic Analysis of Bacterial Resistance Pathways Using Multivalent Quaternary Ammonium Functionalized Macromolecules | Bacteria | Escherichia coli | Pyroglutamate [Data] |
PR000959 | ST001399 | Activation of ectopic olfactory receptor 544 induces GLP-1 secretion, alters gut microbiome, and improves intestinal permeability. | Mammal | Mus musculus | oxoproline [Data] |
PR000960 | ST001400 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria | Human | Homo sapiens | 5-oxoproline [Data] |
PR000960 | ST001516 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) | Human | Homo sapiens | 5-oxoproline [Data] |
PR000960 | ST001517 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) | Human | Homo sapiens | 5-oxoproline [Data] |
PR000961 | ST001401 | Steady-state metabolomics time course of Saccharomyces cerevisiae mitochondrial fatty acid synthesis (mtFAS) mutants | Yeast | Saccharomyces cerevisiae | Pyroglutamic acid [Data] |
PR000967 | ST001411 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Human | Homo sapiens | 5-oxoproline [Data] |
PR000968 | ST001412 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Human | Homo sapiens | 5-oxoproline [Data] |
PR000974 | ST001420 | Metabolomic analysis of patients with recurrent angina | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR000989 | ST001439 | Metabolites in contents of small intestine in wild type and DAOG181R/G181R mice | Bacteria | Mus musculus | 5-Oxoproline [Data] |
PR001003 | ST001479 | Metabolomics of Ndufs4 KO brain regions (part - I) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001003 | ST001483 | Metabolomics of Ndufs4 KO brain regions (part - III) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001003 | ST001485 | Metabolomics of Ndufs4 KO brain regions (part - V) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001003 | ST001487 | Metabolomics of Ndufs4 KO brain regions (part - VII) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001005 | ST001523 | The effect of fasting and sirtuin overexpression on serum metabolome. | Mammal | Mus musculus | oxoproline [Data] |
PR001013 | ST001495 | Effects of Synbiotic Administration on Fecal Microbiome and Metabolomic Profiles of Dogs receiving Antibiotics | Mammal | Canis lupus familiaris | oxoproline [Data] |
PR001022 | ST001515 | A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans | Human | Homo sapiens | 5-oxoproline [Data] |
PR001027 | ST001526 | Mitochondrial health is enhanced in rats with higher vs. lower intrinsic exercise capacity and extended lifespan | Mammal | Rattus norvegicus | oxoproline [Data] |
PR001031 | ST001606 | Aromatic amino acid metabolism by the anaerobic gut bacterium Clostridium sporogenes | Mammal | Mus musculus | oxoproline [Data] |
PR001047 | ST001637 | A Metabolome Atlas of the Aging Mouse Brain | Mammal | Mus musculus | Oxoproline [Data] |
PR001047 | ST001637 | A Metabolome Atlas of the Aging Mouse Brain | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001047 | ST001637 | A Metabolome Atlas of the Aging Mouse Brain | Mammal | Mus musculus | Pyroglutamic acid isomer [Data] |
PR001047 | ST001888 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Mammal | Mus musculus | Oxoproline [Data] |
PR001047 | ST001888 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001047 | ST001888 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Mammal | Mus musculus | Pyroglutamic acid isomer [Data] |
PR001048 | ST001639 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Human | Homo sapiens | 5-oxoproline [Data] |
PR001051 | ST001643 | Deletion of the diabetes candidate gene Slc16a13 in mice | Mammal | Mus musculus | oxoproline [Data] |
PR001053 | ST001719 | Metabolomics Analysis of Philadelphia Cohort - Update (part-I) | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001053 | ST001720 | Metabolomics Analysis of ACTG Cohort -Update (part-II) | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001071 | ST001668 | D-Allulose effects on hepatic metabolomics profile in rodents | Mammal | Rattus norvegicus | Pyroglutamic acid [Data] |
PR001072 | ST001669 | Serum metabolome of Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001089 | ST001699 | A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice (Muscle) part-I | Mammal | Mus musculus | oxoproline [Data] |
PR001089 | ST001700 | A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice (Serum) part-II | Mammal | Mus musculus | oxoproline [Data] |
PR001089 | ST001701 | A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice (Liver) part-III | Mammal | Mus musculus | oxoproline [Data] |
PR001089 | ST001702 | A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice (Heart) part-IV | Mammal | Mus musculus | oxoproline [Data] |
PR001089 | ST001703 | A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice (Brain) part-V | Mammal | Mus musculus | oxoproline [Data] |
PR001103 | ST001721 | Detecting sex-related changes to the metabolome of a critically endangered freshwater crayfish during the mating season | Invertebrate | Cherax tenuimanus | Pyroglutamic acid [Data] |
PR001107 | ST001728 | Metabolomics and metagenomics of metformin (Urine) | Human | Homo sapiens | L-Pyroglutamic acid [Data] |
PR001118 | ST001745 | Metabolomic profiling of the rat hippocampus across developmental ages and after learning | Mammal | Rattus norvegicus | 5-oxoproline [Data] |
PR001121 | ST001749 | REACH Metabolomics Study | Human | Homo sapiens | 5-oxoproline [Data] |
PR001129 | ST001775 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Mammal | Mus musculus | 5-oxoproline [Data] |
PR001133 | ST001780 | Comparative analysis of metabolomic profiles in cerebrospinal fluid before and after endurance exercise | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001133 | ST001789 | Acute metabolomic changes of plasma in response to endurance exercise | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001143 | ST001809 | The Metabolic Benefits of Short Cycles of Very Low Caloric Intake are Dependent on Diet Composition in Middle-Aged Mice | Mammal | Mus musculus | oxoproline [Data] |
PR001148 | ST001815 | Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis | Human | Homo sapiens | oxoproline [Data] |
PR001159 | ST001835 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Human | Homo sapiens | 5-oxoproline [Data] |
PR001162 | ST001841 | Metabolomics of lung microdissections reveals region- and sex-specific metabolic effects of acute naphthalene exposure in mice (part II) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001170 | ST001855 | The metabolomic resetting effect of FG4592 in AKI to CKD transition (Part 1) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001170 | ST001856 | The metabolomic resetting effect of FG4592 in AKI to CKD transition (Part 2) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001178 | ST001865 | Systemic metabolite changes due to Hypoxia | Mammal | Mus musculus | 5-oxoproline [Data] |
PR001178 | ST001866 | Systemic metabolite changes due to PHD inhibition | Mammal | Mus musculus | 5-oxoproline [Data] |
PR001185 | ST001879 | Proteomics reveals an increase in the abundance of glycolytic and ethanolic fermentation enzymes in developing sugarcane culms during sucrose accumulation | Plant | Saccharum spp | L-Proline, 5-oxo-1-(trimethylsilyl)-, trimethylsilyl ester [Data] |
PR001187 | ST001884 | Metabolomics of Ndufs4 KO urine (part - II) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001212 | ST001921 | An Airway Organoid-Based Screen Identifies a Role for the HIF1α-Glycolysis Axis in SARS-CoV-2 Infection | Cultured cells | Homo sapiens | 3-phosphoglyceric acid [Data] |
PR001212 | ST001921 | An Airway Organoid-Based Screen Identifies a Role for the HIF1α-Glycolysis Axis in SARS-CoV-2 Infection | Cultured cells | Homo sapiens | L-pyroglutamic acid [Data] |
PR001213 | ST001922 | Sublytic membrane attack complex drives glycolysis and mitochondrial dysfunction with inflammatory consequences in human monocyte-derived macrophages | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001218 | ST001929 | Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype (Part 2) | Human | Homo sapiens | oxoproline [Data] |
PR001222 | ST001933 | Absolute quantification of plasma cytokines and metabolome reveals the glycylproline regulating antibody-fading in convalescent COVID-19 patients | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001226 | ST001937 | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules | Human | Homo sapiens | oxoproline [Data] |
PR001228 | ST001940 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Human | Homo sapiens | 5-oxoproline [Data] |
PR001233 | ST001946 | Bipolar disorder metabolomics analysis using FiehnLib and GMD for curation | Human | Homo sapiens | L-pyroglutamic acid [Data] |
PR001252 | ST001966 | NMR Hydrophilic Metabolomic Analysis of Bacterial Resistance Pathways using Multivalent Antimicrobials with Challenged and Unchallenged Wild Type and Mutated Gram Positive Bacteria | Bacteria | Bacillus cereus | Pyroglutamate [Data] |
PR001253 | ST001968 | Analytical methodology for a metabolome atlas of goat’s plasma, milk and feces using 1H-NMR and UHPLC-HRMS:MS/plasma | Mammal | Capra hircus | Pyroglutamic acid [Data] |
PR001253 | ST001970 | Analytical methodology for a metabolome atlas of goat’s plasma, milk and feces using 1H-NMR and UHPLC-HRMS:MS/milk | Mammal | Capra hircus | Pyroglutamic acid [Data] |
PR001253 | ST001973 | Analytical methodology for a metabolome atlas of goat’s plasma, milk and feces using 1H-NMR and UHPLC-HRMS:MS/feces | Mammal | Capra hircus | Pyroglutamic acid [Data] |
PR001262 | ST001986 | Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells | Cultured cells | Mus musculus | pyroglutamate [Data] |
PR001269 | ST002000 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 1) | Human | Homo sapiens | oxoproline [Data] |
PR001276 | ST002012 | Untargeted primary metabolite profiling in Arabidopsis thaliana | Plant | Arabidopsis thaliana | oxoproline [Data] |
PR001281 | ST002017 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Human | Homo sapiens | 5-oxoproline [Data] |
PR001281 | ST002018 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Human | Homo sapiens | 5-oxoproline [Data] |
PR001282 | ST002019 | TIPs Metabolomics (blood) | Human | Homo sapiens | 5-oxoproline [Data] |
PR001282 | ST002020 | TIPs Metabolomics (urine) | Human | Homo sapiens | 5-oxoproline [Data] |
PR001287 | ST002027 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Serum/HILIC) | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001287 | ST002028 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/HILIC) | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001290 | ST002043 | Maternal Hypoxemia and Oxidative Stress | Mammal | Ovis aries | oxoproline [Data] |
PR001320 | ST002080 | Effects of Ferroptosis on the Metabolome in Cardiac Cells: The Role of Glutaminolysis | Cultured cells | Rattus norvegicus | 5-oxoproline [Data] |
PR001340 | ST002115 | LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells | Cultured cells | Homo sapiens | pyroglutamate [Data] |
PR001366 | ST002153 | Data from plasma metabolome analysis of APP-KI and Wild type mice treated with B. breve MCC1274 | Mammal | Mus musculus | 5-Oxoproline [Data] |
PR001398 | ST002194 | Metabolic profiling at COVID-19 onset shows disease severity and sex-specific dysregulation | Human | Homo sapiens | L-5-Oxoproline [Data] |
PR001409 | ST002206 | Lipolysis-derived Lipids Determine Autophagy Initiation during Fasting | Invertebrate | Caenorhabditis elegans | 5-Oxoproline [Data] |
PR001416 | ST002216 | Non-targeted metabolomics screen comparing metabolite profiles of serum from PDAC-bearing mice that received metronidazole using high-resolution, high-performance LC-MS/MS analysis. | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001418 | ST002220 | Catabolism of branched-chain amino acids (BCAAs) in renal cells HK2 and 786-O | Cultured cells | Homo sapiens | pyroglutamate_m+0 [Data] |
PR001418 | ST002220 | Catabolism of branched-chain amino acids (BCAAs) in renal cells HK2 and 786-O | Cultured cells | Homo sapiens | pyroglutamate_m+1 [Data] |
PR001418 | ST002220 | Catabolism of branched-chain amino acids (BCAAs) in renal cells HK2 and 786-O | Cultured cells | Homo sapiens | pyroglutamate_m+2 [Data] |
PR001418 | ST002221 | Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+0 [Data] |
PR001418 | ST002221 | Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+1 [Data] |
PR001418 | ST002221 | Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+2 [Data] |
PR001418 | ST002221 | Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+3 [Data] |
PR001418 | ST002221 | Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+4 [Data] |
PR001418 | ST002221 | Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+5 [Data] |
PR001418 | ST002222 | Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+0 [Data] |
PR001418 | ST002222 | Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+1 [Data] |
PR001418 | ST002222 | Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+2 [Data] |
PR001418 | ST002222 | Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+3 [Data] |
PR001418 | ST002222 | Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+4 [Data] |
PR001418 | ST002222 | Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC | Cultured cells | Homo sapiens | pyroglutamate_m+5 [Data] |
PR001418 | ST002223 | Metabolic profiling of mouse tissues and tissue interstitial fluids | Mammal | Mus musculus | pyroglutamate [Data] |
PR001418 | ST002224 | Intracellular metabolic profile of renal cells cultured in Plasmax | Cultured cells | Homo sapiens | pyroglutamate [Data] |
PR001418 | ST002225 | Time sensitive contribution of the BCAA catabolism to the TCA cycle carbons in HK2, 786-O, OS-RC-2 and RFX-631 | Cultured cells | Homo sapiens | pyroglutamate [Data] |
PR001418 | ST002226 | Exometabolomics of HK2, 786-O cells cultured in Plasmax media | Cultured cells | Homo sapiens | pyroglutamate [Data] |
PR001419 | ST002228 | Estrogen receptor a deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 2) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001431 | ST002242 | Hypoxia promotes osteogenesis via regulating the acetyl-CoA-mediated mito-nuclear communication. | Cultured cells | Mus musculus | pyroglutamate [Data] |
PR001432 | ST002244 | Metabolomics analysis of Friedreich's ataxia (FRDA) (part I) | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001467 | ST002287 | Enhanced systemic commensal E. coli immunogenicity through minor alteration of the metabolic profile | Bacteria | Escherichia coli | Pyroglutamic acid [Data] |
PR001468 | ST002289 | Map of microbially induced metabolic changes across diverse body sites in mice - Bacterial culture data | Bacteria | Several mouse commensals | Pyroglutamic acid [Data] |
PR001468 | ST002465 | Map of microbially induced metabolic changes across diverse body sites in mice - Mouse Data | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001500 | ST002337 | Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001530 | ST002380 | Metabolomic and Cultivation Insights into the Tolerance of the Spacecraft-Associated Acinetobacter Towards Kleenol 30, a Cleanroom Floor Detergent | Bacteria | Acinetobacter | oxoproline [Data] |
PR001562 | ST002428 | Mass Spectrometry-based Proteomic and Metabolomic profiling of serum samples for discovery and validation of Tuberculosis diagnostic biomarker signature | Human | Homo sapiens | D-(+)-Pyroglutamic Acid [Data] |
PR001580 | ST002450 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 1 of 3) | Cultured cells | Mus musculus | Pyroglutamic acid [Data] |
PR001580 | ST002451 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001580 | ST002451 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) | Mammal | Mus musculus | Pyroglutamic acid_13C_1 [Data] |
PR001580 | ST002451 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) | Mammal | Mus musculus | Pyroglutamic acid_13C_2 [Data] |
PR001580 | ST002451 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) | Mammal | Mus musculus | Pyroglutamic acid_13C_3 [Data] |
PR001580 | ST002451 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) | Mammal | Mus musculus | Pyroglutamic acid_13C_4 [Data] |
PR001580 | ST002451 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) | Mammal | Mus musculus | Pyroglutamic acid_13C_5 [Data] |
PR001585 | ST002457 | Mouse kidney metabolomics (Whole kidney) | Mammal | Mus musculus | Oxoproline [Data] |
PR001606 | ST002484 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: primary metabolism | Human | Homo sapiens | oxoproline [Data] |
PR001609 | ST002493 | Composition of raw plant-based food items Pilot Study | Plant | Malus domestica/Solanum lycopersicum/Lactuca sativa/Fragaria x ananassa/Allium sativum/Ocimum basilicum | oxoproline [Data] |
PR001636 | ST002540 | Deriving Schwann Cells from hPSCs Enables Disease Modeling and Drug Discovery for Diabetic Peripheral Neuropathy | Cultured cells | Homo sapiens | oxoproline [Data] |
PR001648 | ST002556 | Blood metabolomics and impacted cellular mechanisms during transition into lactation in dairy cows that develop metritis | Mammal | Bos taurus | oxoproline [Data] |
PR001665 | ST002585 | Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo | Mammal | Rattus norvegicus | oxoproline [Data] |
PR001700 | ST002736 | Assessing mitochondrial bioenergetics in coronary artery disease: A translational multiomic tissue study in humans (The AMBITION study). | Human | Homo sapiens | pyroglutamic acid [Data] |
PR001719 | ST002758 | Metabolic responses of normal rat kidneys to a high salt intake (Plasma) | Mammal | Rattus norvegicus | L-Pyroglutamic acid [Data] |
PR001719 | ST002759 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Mammal | Rattus norvegicus | L-Pyroglutamic acid [Data] |
PR001719 | ST002761 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Mammal | Rattus norvegicus | L-Pyroglutamic acid [Data] |
PR001748 | ST002801 | Investigation of metabolism in hypertrophic cardiomyopathy | Mammal | Mus musculus | Oxoproline [Data] |
PR001762 | ST002818 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Human | Homo sapiens | 5-oxoproline [Data] |
PR001762 | ST002819 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Human | Homo sapiens | 5-oxoproline [Data] |
PR001762 | ST002820 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Human | Homo sapiens | 5-oxoproline [Data] |
PR001767 | ST002825 | Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) | Human | Homo sapiens | oxoproline [Data] |
PR001776 | ST002836 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Intestine) | Mammal | Mus musculus | 5-oxoproline [Data] |
PR001776 | ST002837 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Blood) | Mammal | Mus musculus | 5-oxoproline [Data] |
PR001823 | ST002931 | Analyzing Metabolic Alterations in the Gut, Blood, and Brain of Mice Induced by Running Exercise Through Gas Chromatography Mass Spectrometry. | Mammal | Mus musculus | Pyroglutamic acid [Data] |
PR001835 | ST002952 | Investigate the impact of feeding time on the hexosamine biosynthetic pathway (HBP) in the mouse liver and heart using targeted metabolomics: primary metabolism | Mammal | Mus musculus | oxoproline [Data] |
PR001863 | ST002993 | Identifying subgroups of childhood obesity by using multiplatform metabotyping | Human | Homo sapiens | Pyroglutamic acid [Data] |
PR001864 | ST002994 | Integrating uterine microbiome and metabolome to advance the understanding of the uterine environment in dairy cows with metritis | Mammal | Bos taurus | oxoproline [Data] |
PR001910 | ST003064 | Metabolic responses of Amaranthus caudatus roots and leaves to zinc stress | Plant | Amaranthus caudatus L. | Pyroglutamic acid [Data] |
PR001910 | ST003064 | Metabolic responses of Amaranthus caudatus roots and leaves to zinc stress | Plant | Amaranthus caudatus L. | Pyroglutamic acid_1TMS [Data] |
PR001910 | ST003064 | Metabolic responses of Amaranthus caudatus roots and leaves to zinc stress | Plant | Amaranthus caudatus L. | Pyroglutamic acid_2TMS [Data] |
PR001945 | ST003131 | Untargeted Metabolomics on mouse caecal contents | Mammal | Mus musculus | 5-oxoproline [Data] |
PR001945 | ST003132 | Untargeted Metabolomics on Mouse colonic mucosa | Mammal | Mus musculus | 5-oxoproline [Data] |